01.04.2022 • NewsSolvay

Solvay Settles Patent Dispute with China’s HySci

Solvay has reached full and final financial settlement with China’s HySci (Tianjin) Specialty Materials over a patent infringement suit for rare earth oxides.

The settlement relates to a judgement issued back in 2015 in favor of Solvay by the Tianjin 2nd Intermediate People’s Court and further confirmed by the Supreme People's Court. The ruling found that HySci had infringed the Belgian company’s Chinese patents and ordered it to cease producing and selling the products and pay material damages.

Rare earth oxides are used in automotive catalysts to abate noxious gases from engine exhausts. Solvay said that ever stricter air quality standards are requiring increasingly complex formulated rare earth oxides that have been developed after extensive research and innovation.

Author: Elaine Burridge, Freelance Journalist

©Solvay/Mathias Guillin
©Solvay/Mathias Guillin

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.